Area of research
Molecular Biology · Nutrition and Dietetics
Research interest
Research interests include Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, Vitamin C and Antioxidants Research, and Protein Degradation and Inhibitors.
Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials
Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma
Vitamin C Deficiency in Blood Samples of COVID-19 Patients
Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model
Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy
Short-term oxaliplatin exposure according to established hyperthermic intraperitoneal chemotherapy (HIPEC) protocols lacks effectiveness <i>in vitro</i> and <i>ex vivo</i>
6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells
Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
Enhanced killing of therapy‐induced senescent tumor cells by oncolytic measles vaccine viruses
Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
Kaempferol, ein neuer natürlicher pan-Inhibitor humaner Histondeacetylasen
Kaempferol, ein neuer natürlicher Histondeacetylase-Inhibitor
Entwicklung, Charakterisierung und Evaluierung neuartiger auf Naturstoffen basierender Histondeacetylase-Inhibitoren für die Therapie solider Tumore